<p>Fresenius Medical Care AG has appointed Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board, effective January 1, 2026. He will succeed Franklin W. Maddux, who will retire at the end of the year. Charles Hugh-Jones previously served as CEO of Volastra Therapeutics and held senior roles at Allergan, Pfizer, and Sanofi. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>Fresenius Medical Care AG has appointed Charles Hugh-Jones as Global Chief Medical Officer, effective January 1, 2026. He will join the Management Board, succeeding Franklin W. Maddux, who retires at year-end. Hugh-Jones previously held senior roles at Volastra Therapeutics, Allergan, Pfizer, and Sanofi.</p>

Fresenius Medical Care Appoints Charles Hugh-Jones as Global Chief Medical Officer